Liver disease in cystic fibrosis.

This publication has 41 references indexed in Scilit:

• Ursodeoxycholic acid reduces the systemic toxicity of 1, 2-dichloro, 4-nitrobenzene by stimulating hepatic glutathione S-transferase in mice
  Life Sciences, 1994
• Analysis of risk factors for the development of liver disease associated with cystic fibrosis
  The Journal of Pediatrics, 1994
• Cystic fibrosis gene and mucin secretion
  The Lancet, 1994
• Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasis
  The Journal of Pediatrics, 1992
• Genotype Analysis for ΔF508, G551d and R553x Mutations in Children and Young Adults With Cystic Fibrosis With and Without Chronic Liver Disease
  Hepatology, 1992
• Ursodeoxycholic acid in chronic liver disease.
  Gut, 1991
• Prevalence of liver disease in cystic fibrosis.
  Archives of Disease in Childhood, 1991
• Severity of cystic fibrosis in patients homozygous and heterozygous for ΔF508 mutation
  The Lancet, 1991
• Liver disease and bileduct stenosis in cystic fibrosis
  The Lancet, 1990
• Liver disease and biliary tract abnormalities in cystic fibrosis
  The Lancet, 1990